Scientists have developed a new compound which interacts with the same therapeutic targets in the brain as psychedelic drugs, producing the same long-lasting antidepressant and antianxiety effects but without the psychedelic high.
California’s cannabis regulator will provide $20 million in funding for new cannabis-related research.
James Rucker, a consultant psychiatrist at King's College London, breaks down the good psychedelic research from the bad. via the Conversation.
The new essay highlights numerous ethical concerns currently facing the field and emphasizes the importance of acknowledging wisdoms already known to Indigenous people.
Use ultrasound-assisted extraction to prepare solid edibles for analysis, and use solid-phase extraction for beverages, scientists recommend.
Ketamine can help people with treatment-resistant depression by breaking their entrenched belief systems, according to a recent paper.